Lipoprotein (a) test
About the parameter
The protein is believed to be inherited as an autosomal dominant trait and appears to be insensitive to either diet, lifestyle or most hypolipidaemic drugs. The characteristic feature of Lp (a) is that it is distinct from all other serum proteins and apolipoproteins. Since its discovery in 1963 there has been a considerable rise in interest, not only in specialised research centers but also in clinical laboratories, in the accurate measurement of Lipoprotein (a) in blood.
This interest was stimulated by reports indicating that levels above 20 – 30 mg/dl present in approx. 25% of the population are associated with an increased risk of coronary heart disease. Many investigators have confirmed that high Lipoprotein (a) concentrations represent an indicator of risk for cardiovascular diseases, especially when serum LDL or APO B are elevated.
Therefore a convenient and reliable method for the quantification of Lp (a) in serum or plasma is important for identifying individuals at risk for developing arteriosclerosis.
The test is a kinetic measurement of the Lp (a) concentration at 700 nm (Absorbance).
This is a kinetic test based on a latex-immunoturbidimetric measurement.
Serum / Plasma:
0 – 100 mg/dl for (LOT dependent)
This test takes approx. 5 minutes.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser Lipoprotein (a) assay here: Evaluation Eurolyser Lipoprotein
Please note: depending on the time of the market launch of an assay, the respective assay evaluation was carried out using either a Eurolyser smart instrument or a Eurolyser CUBE instrument.
Since the measurement method is the same in both instruments (their photometric units are identical in construction), as was proved in this comparison study, all testkit evaluations provided on this website are valid for either instrument!
ST 0141 Lipoprotein (a) test kit (containing 16 tests)
ST 1400 Lipoprotein (a) control kit (decision level)
7. February 2019
Sysmex Corporation, Japan and EUROLYSER, Austria to expand their co-operation in the Japan...» Read more...
4. December 2018
PSA (prostate specific antigen): Elevate prostatic diseases with Eurolyser’s new ass...» Read more...
21. November 2018
K+ Potassium: A new veterinary test for heart and lung muscle function assessment...» Read more...
26. September 2018